Magid-Haffner Associates, Inc. has the capabilities to take a product from inception through development to USFDA approval.

Magid-Haffner Associates, Inc. can act as liaison for your company with the USFDA by providing assistance with the submission of IND, NDA, ANDA and DMF documentation, attendance at USFDA presentation and review meetings, and expediting of the final approval of the drug products resulting in U.S. distribution.

With our overseas office, M.H.A. (UK) Ltd., located just outside Manchester, we have the capability and expertise to meet with international regulatory agencies, such as the UK MCA, German BfArM and the Danish Medicines Agency, on behalf of our clients to help expedite product approvals or resolve regulatory issues.

"Compliance should improve the overall operation, quality and efficiency of the operation while achieving compliance, and having a positive impact on the corporation's bottom line."